Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
Go back to Eliquis, Orencia sales propel Bristol-Myers to strong second quarter| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 57.13 +0.23 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.90 | 52 Week High | $77.12 | |||
| Open | $57.45 | 52 Week Low | $49.03 | |||
| Day High | $57.60 | P/E | 37.10 | |||
| Day Low | $56.77 | EPS | $1.54 | |||
| Volume | 7,839,148 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 119.05 -1.71 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.76 | 52 Week High | $65.46 | |||
| Open | $121.50 | 52 Week Low | $47.97 | |||
| Day High | $121.90 | P/E | 80.99 | |||
| Day Low | $118.83 | EPS | $1.47 | |||
| Volume | 10,927,028 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.21 +0.04 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.17 | 52 Week High | $37.39 | |||
| Open | $26.29 | 52 Week Low | $28.25 | |||
| Day High | $26.49 | P/E | 15.88 | |||
| Day Low | $26.11 | EPS | $1.65 | |||
| Volume | 38,768,485 | |||||
